Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD.
Bourbeau J, Bafadhel M, Barnes NC, Compton C, Di Boscio V, Lipson DA, Jones PW, Martin N, Weiss G, Halpin DMG. Bourbeau J, et al. Int J Chron Obstruct Pulmon Dis. 2021 Mar 1;16:499-517. doi: 10.2147/COPD.S291967. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33688176 Free PMC article. Review.
Preventing hospitalization for COPD exacerbations.
Bourbeau J. Bourbeau J. Semin Respir Crit Care Med. 2010 Jun;31(3):313-20. doi: 10.1055/s-0030-1254071. Epub 2010 May 21. Semin Respir Crit Care Med. 2010. PMID: 20496300 Review.
A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD.
Agustí A, de Teresa L, De Backer W, Zvarich MT, Locantore N, Barnes N, Bourbeau J, Crim C. Agustí A, et al. Among authors: bourbeau j. Eur Respir J. 2014 Mar;43(3):763-72. doi: 10.1183/09031936.00054213. Epub 2013 Oct 10. Eur Respir J. 2014. PMID: 24114969 Free article. Clinical Trial.
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.
Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Sanford L, Lettis S, Crim C, Calverley PM. Dransfield MT, et al. Among authors: bourbeau j. Lancet Respir Med. 2013 May;1(3):210-23. doi: 10.1016/S2213-2600(13)70040-7. Epub 2013 Apr 12. Lancet Respir Med. 2013. PMID: 24429127 Clinical Trial.
Derivation of normative data for the COPD assessment test (CAT).
Pinto LM, Gupta N, Tan W, Li PZ, Benedetti A, Jones PW, Bourbeau J; CanCOLD study group. Pinto LM, et al. Among authors: bourbeau j. Respir Res. 2014 Jun 23;15(1):68. doi: 10.1186/1465-9921-15-68. Respir Res. 2014. PMID: 24957783 Free PMC article.
The COPD assessment test: a systematic review.
Gupta N, Pinto LM, Morogan A, Bourbeau J. Gupta N, et al. Among authors: bourbeau j. Eur Respir J. 2014 Oct;44(4):873-84. doi: 10.1183/09031936.00025214. Epub 2014 Jul 3. Eur Respir J. 2014. PMID: 24993906 Free article. Review.
406 results